Safety and Performance Study of the Moderato System

NACompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

November 30, 2015

Study Completion Date

August 31, 2017

Conditions
Hypertension Resistant to Conventional TherapyBradycardiaAtrioventricular Block
Interventions
DEVICE

The Moderato System

The BackBeat Moderato System incorporates traditional pacing modes and algorithms to provide pacing support to patients with all conditions currently indicated for dual chamber pacing. In addition, a special pacing algorithm was developed to reduce blood pressure.

Trial Locations (10)

1002

P. Stradins Clinical University Hospital, Riga

1090

Medical University Vienna, Vienna

1100

Academic Medical Center - University of Amsterdam, Amsterdam

1122

Semmelweis University Heart and Vascular Center, Budapest

3584

University Medical Center Utrecht, Utrecht

4020

Krankenhaus der Elisabethinen, Linz

Unknown

Clinica Tabancura, Santiago

Hospital Dr. Sotero del Rio, Santiago

Na Homolce Hospital, Prague

08661

Vilnius University Hospital Santariskiu Klinikos, Vilnius

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Massachusetts General Hospital

OTHER

collaborator

MLM Medical Labs GmbH

INDUSTRY

collaborator

nabios GmbH

UNKNOWN

lead

BackBeat Medical Inc

INDUSTRY

NCT02282033 - Safety and Performance Study of the Moderato System | Biotech Hunter | Biotech Hunter